521 related articles for article (PubMed ID: 17030119)
1. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
[TBL] [Abstract][Full Text] [Related]
2. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].
Sivadon V; Orlikowski D; Rozenberg F; Quincampoix JC; Caudie C; Durand MC; Fauchère JL; Sharshar T; Raphaël JC; Gaillard JL
Pathol Biol (Paris); 2005; 53(8-9):536-8. PubMed ID: 16084033
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barre syndrome in children.
Tabarki-Melaiki B
Neurosciences (Riyadh); 2011 Apr; 16(2):174-5. PubMed ID: 21427674
[No Abstract] [Full Text] [Related]
5. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
Tam CC; Rodrigues LC; O'Brien SJ
Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
[TBL] [Abstract][Full Text] [Related]
7. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
[TBL] [Abstract][Full Text] [Related]
10. [Guillain-Barre syndrome: etiology and pathogenesis].
Avila-Funes JA; Mariona-Montero VA; Melano-Carranza E
Rev Invest Clin; 2002; 54(4):357-63. PubMed ID: 12415961
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome: association with Campylobacter jejuni and Mycoplasma pneumoniae infections in India.
Gorthi SP; Kapoor L; Chaudhry R; Sharma N; Perez-Perez GI; Panigrahi P; Behari M
Natl Med J India; 2006; 19(3):137-9. PubMed ID: 16836263
[TBL] [Abstract][Full Text] [Related]
12. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
13. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study.
Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B
J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection.
Rajabally YA; Ramlackhansingh A; Fraser M; Abbott RJ
Neurophysiol Clin; 2009 Aug; 39(3):135-8. PubMed ID: 19716463
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barre syndrome and Campylobacter infection.
Prasad KN; Pradhan S; Nag VL
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):527-30. PubMed ID: 11944711
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
Hagensee ME; Benyunes M; Miller JA; Spach DH
Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
[TBL] [Abstract][Full Text] [Related]
19. [Campylobacter jejuni infection in patient with Guillain-Barré syndrome: a case report].
Kopyta I; Wardak S
Med Dosw Mikrobiol; 2008; 60(1):59-63. PubMed ID: 18634345
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
